Your browser doesn't support javascript.
loading
Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study.
Lau, David; Kalaitzaki, Eleftheria; Church, David N; Pandha, Hardev; Tomlinson, Ian; Annels, Nicola; Gerlinger, Marco; Sclafani, Francesco; Smith, Gillian; Begum, Ruwaida; Crux, Richard; Gillbanks, Angela; Wordsworth, Sarah; Chau, Ian; Starling, Naureen; Cunningham, David; Dhillon, Tony.
Afiliação
  • Lau D; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Kalaitzaki E; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Church DN; Wellcome Centre for Human Genetics, University of Oxford, Oxford, Oxfordshire, UK.
  • Pandha H; University of Surrey, Guildford, Surrey, UK.
  • Tomlinson I; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Annels N; University of Surrey, Guildford, Surrey, UK.
  • Gerlinger M; Institute of Cancer Research, London, UK.
  • Sclafani F; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Smith G; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Begum R; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Crux R; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Gillbanks A; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Wordsworth S; Nuffield Department of Population Health, University of Oxford, Oxford, Oxfordshire, UK.
  • Chau I; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Starling N; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Cunningham D; Royal Marsden Hospital NHS Foundation Trust, London, UK.
  • Dhillon T; Royal Surrey NHS Foundation Trust, Guildford, UK t.dhillon@surrey.ac.uk.
ESMO Open ; 5(1)2020 02.
Article em En | MEDLINE | ID: mdl-32079623

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Exonucleases / Reparo de Erro de Pareamento de DNA / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo / Exonucleases / Reparo de Erro de Pareamento de DNA / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article